Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System

Similar documents
A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

Determination of Benzodiazepines in Urine by CE-MS/MS

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Automated Targeted screening of Benzodiazepines in urine using LDTD-MS/MS at 400 samples per hour rate

Analyze Barbiturates in Urine with Agilent 6430 LC/MS/MS and Poroshell 120 EC-C18

Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer

Rapid Hydrolysis of Benzodiazepines in Urine. Alicia Zook 1 and Crystal Xander B.S. 2. Cedar Crest College, Allentown, PA 1

A FORENSIC TOXICOLOGY METHOD FOR THE DETERMINATION OF DESOMORPHINE, HEROIN, METHADONE, BUPRENORPHINE AND METABOLITES IN URINE USING LC/MS QQQ

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Application Note. Author. Abstract. Introduction. Food Safety

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

Improving Benzodiazepine Immunoassay Sensitivity by Rapid Glucuronide Hydrolysis Technology

Analysis of Acrylamide in French Fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Rapid and Robust Detection of THC and Its Metabolites in Blood

Mycotoxin Analysis in Peanut Butter Using Captiva EMR Lipid Cleanup and LC/MS/MS

Quantitative Determination of Drugs of Abuse in Human Plasma and Serum by LC/MS/MS Using Agilent Captiva EMR Lipid Cleanup

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

Cannabinoid Quantitation Using an Agilent 6430 LC/MS/MS

Determination of Amphetamine and Derivatives in Urine

Quantitative Determination of Drugs of Abuse in Human Whole Blood by LC/MS/MS Using Agilent Captiva EMR Lipid Cleanup

Offline and online sample extraction for the quantification of benzodiazepines in human plasma or serum for clinical research

Extended Mass Range Triple Quadrupole for Routine Analysis of High Mass-to-charge Peptide Ions

LC-MS/MS analysis of Chlorates in Milk and Whey Powder using the Agilent 6470 QQQ

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Quantitative Analysis of Amphetamine-Type Drugs by Extractive Benzoylation and LC/MS/MS. Application. Introduction. Authors. Abstract.

Mycotoxin Analysis in Infant Formula Using Captiva EMR Lipid Cleanup and LC/MS/MS

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

LC/MS/MS Separation of Cholesterol and Related Sterols in Plasma on an Agilent InfinityLab Poroshell 120 EC C18 Column

Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS

LC/MS/MS of Trichothecenes and Zearalenone in Wheat Using Different Sample Prep Methods

Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System

Determination of Gamma-Hydroxy-Butyrate (GHB) in Biological Samples

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

Modified QuEChERS for HILIC LC/MS/MS Analysis of Nicotine and Its Metabolites in Fish

Detection of Cotinine and 3- hydroxycotine in Smokers Urine

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites

Analysis of mycotoxins in food matrices using the Agilent Ultivo Triple Quadrupole LC/MS

Authors. Abstract. Forensic Toxicology. Irina Dioumaeva, John M. Hughes Agilent Technologies, Inc.

AppNote 4/2015. Automated Desorption, SPE Extraction, and LC/MS/MS Analysis of Dried Blood Spots KEYWORDS ABSTRACT

Detection, Confirmation, and Quantification of Chloramphenicol in Honey, Shrimp and Chicken Using the Agilent 6410 LC/MS Triple Quadrupole

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Quantitation of Protein Phosphorylation Using Multiple Reaction Monitoring

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

Determination of Amantadine Residues in Chicken by LCMS-8040

Author. Introduction. Small Molecule Pharmaceuticals & Generics

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Agilent Clinical LC/MS: Review of Established LC-MS QQQ Clinical Research Applications. dr. Jan Srbek, HPST. Page 1

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Author. Introduction. Abstract

All stocks and calibration levels were prepared in water: methanol (50:50) v/v to cover range of all steroid concentrations (refer Table 1).

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

Determination of Bath Salts (Pyrovalerone Analogs) in Biological Samples

High Throughput Workflow for Global Metabolomic Profiling of Biological Samples with RapidFire online SPE/MS system

Supporting Information

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab

Drugs of Abuse in Oral Fluids: Automated SPE Extraction and LC/MS/MS Determination using a Robotic Autosampler

Application Note. Abstract. Authors. Pharmaceutical

Abstract. Introduction

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

LC/MS/MS Analysis of Gabapentin, and Opiates. Applications. Presentation Outline. Polarity, MW and Volatility LC/MS Triple Quad Components

Application. Detection of Cannabinoids in Oral Fluid Using Inert Source GC/MS. Introduction. Authors. Abstract. Forensic Toxicology

Determination of B-vitamins in Energy Drinks by CE/MS/MS

Simultaneous Analysis of Amino Acids and Acylcarnitines in Dried Blood Spots

Efficient Quantitative Analysis of THC and Metabolites in Human Plasma Using Agilent Captiva EMR Lipid and LC-MS/MS

Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

Integration of steroids analysis in serum using LC-MS/MS with full-automated sample preparation

Overview. Introduction. Experimental. Cliquid Software for Routine LC/MS/MS Analysis

Separation of Polyphenols by Comprehensive 2D-LC and Molecular Formula Determination by Coupling to Accurate Mass Measurement

LCMS-8030 Application Report. Steroids: Testosterone, Progesterone, Estradiol, Ethinylestradiol

LC/MS Method for Comprehensive Analysis of Plasma Lipids

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Analysis of Vitamins Using an SFC/UHPLC Hybrid System with a Triple Quadrupole LC/MS for Quantification

Quantitative Analysis of Underivatized Amino Acids in Plant Matrix by Hydrophilic Interaction Chromatography (HILIC) with LC/MS Detection

Analysis of Cholesterol-Lowering Drugs (Statins) Using Dried Matrix Spot Technology

Multiclass Mycotoxin Analysis in Cheese Using Agilent Captiva EMR Lipid Cleanup and LC/MS/MS

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

Application Note. Small Molecule Pharmaceuticals. 2-Ethyl-2-phenylmalonamide Ethosuximide Primidone Carbamazepine. Carbamazepine-

Highly sensitive simultaneous quantitative analysis of estrone and equilin from plasma using LC/MS/MS

BETA-GLUCURONIDASE PRODUCT LINE INNOVATION THROUGH CHEMISTRY. FORENSICS

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology

Determination of red blood cell fatty acid profiles in clinical research

Two-Dimensional LC/MS/MS to Reduce Ion Suppression in the Determination of Cannabinoids in Blood Plasma

Determination of Benzodiazepines in Oral Fluid using LC MS MS

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

Determination of Isoflavones in Soybean by LC/MS/MS

LC-MS/MS Method for the Determination of Tenofovir from Plasma

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

Transcription:

Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System Application Note Forensic Toxicology Authors Nikunj R. Parikh, Michelle Romm, and Vaughn P. Miller Agilent Technologies, Inc. 11 Audubon Rd, Wakefield, MA 188 Abstract The need for greater analytical capacity and throughput for the analysis of benzodiazepines in urine for forensic toxicology has placed demands on traditional analytical technologies. An ultrafast method for quantifying six benzodiazepines as a panel in urine was developed using an Agilent RapidFire High-throughput Mass Spectrometry system. Alpha-hydroxyalprazolam, lorazepam, temazepam, oxazepam, and 7-aminoclonazepam were accurately and precisely measured within a linear range of 12,. All fi ve analytes and a common internal standard, nordiazepam-d, were simultaneously measured at 14 seconds per sample, providing a throughput of greater than 2 samples per hour. H H H H Alpha-hydroxyalprazolam Lorazepam Temazepam H H NH 2 H xazepam 7-Aminoclonazepam Figure 1. Chemical structures of the five benzodiazepines in the panel.

Introduction Traditionally, the quantification of benzodiazepines involves analysis by immunoassays followed by a confirmatory test by GC/MS and more recently by LC/MS assays. The steady increase in sample volume has led to the need for greater analytical capacity within forensic toxicology laboratories, placing a strain on traditional technologies. In the present study, we evaluated the ability of the Agilent RapidFire High-throughput Mass Spectrometry System, an ultrafast SPE/MS/MS system, to quantitate across different drugs of a benzodiazepine class (Figure 1) in urine at low concentrations, with sample cycle times of under 1 seconds per sample. Experimental The RapidFire/MS/MS system consisted of the following modules: an Agilent RapidFire 36, an Agilent 649 Triple Quadruple Mass Spectrometer, MassHunter Qualitative Analysis B.., and MassHunter Quantitative Analysis B... Samples were analyzed at a rate of 14 seconds per sample. Analyte and internal standard ions were monitored simultaneously in all experiments for all five benzodiazepine drugs. Chemicals and reagents Alpha-hydroxyalprazolam, lorazepam, temazepam, oxazepam, 7-aminoclonazepam, and nordiazepam-d (1. mg/ml in methanol) were purchased from Cerilliant, Round Rock, TX. All other solvents and reagents were purchased from Sigma-Aldrich, St. Louis, M. Table 1. RapidFire/MS/MS Conditions. RapidFire conditions Buffer A Water; 1. ml/min flow rate Buffer B 1 % Acetonitrile; 1.2 ml/min flow rate Buffer C : Methanol:Isopropanol +.1 % Formic acid; 1.2 ml/min flow rate Back chimney wash Water (aqueous), Methanol (organic) Injection volume 1 µl SPE cartridge Agilent RapidFire cartridge A2 (reversed-phase C4 chemistry, G92A) RF State 1 sip sensor RF State 2 3, ms RF State 3 3, ms RF State 4, ms RF State ms Triple quadrupole conditions Gas temperature 2 C Gas flow 14 L/min Nebulizer 4 psi Sheath gas temperature 2 C Sheath gas flow 11 L/min Nozzle voltage V Capillary voltage 3, V Time filtering peak width.3 Table 2. MRM transitions. Compound ID Q1 Q3 Frag CE Dwell CAV Alpha-Hydroxyalprazolam 32.1 297.1 38 28 2 4 Alpha-Hydroxyalprazolam 32.1 21.9 38 44 2 4 Lorazepam 321 27 38 21 2 4 Lorazepam 321 229 38 3 2 4 Temazepam 31.1 2.1 38 29 2 4 Temazepam 31.1 177 38 4 2 4 xazepam 287.1 241.2 38 21 2 4 xazepam 287.1 14 38 36 2 4 7-Aminoclonazepam 286.1 222.1 38 2 2 4 7-Aminoclonazepam 286.1 121.1 38 33 2 4 Nordiazepam-D (IS) 276.1 16.1 38 31 2 3 Nordiazepam-D (IS) 276.1 14.1 38 31 2 3 2

Sample preparation Pooled standard calibrators were prepared by spiking 12, of each of the above mentioned drugs into drug-free human urine. Serial dilutions were used to achieve the remaining standard calibration concentrations. Fifty microliters of 1 M sodium acetate ph containing the internal standard nordiazepam-d at was added to 2 µl of each sample and vortexed. Next, 1 µl of b-glucuronidase was added to each sample, vortexed and incubated between 6 C for 2 hours. Post incubation, the samples were vortexed again and then centrifuged at 1, rpm for minutes. Samples were then diluted 1: with water, transferred to 96 well-plates and centrifuged prior to injection on the Agilent RapidFire/MS system. Data analysis The peak integration was performed using the Agilent MassHunter Quantitative analysis software. The AUC of each analyte was normalized by the AUC of nordiazepam-d internal standard. The entire dataset was subjected to linear regression with 1/x weighting. Results and Discussion Samples were prepared by spiking benzodiazepines into drug-free human urine followed by an incubation with glucuronidase and then dilution with water (1:). Samples were then analyzed by SPE/MS/MS using the RapidFire/MS/MS system and a reversed phase C4 cartridge at 14 seconds per sample. This RapidFire/MS/MS methodology is capable of throughputs greater than 2 samples per hour providing a high-throughput and very efficient analysis. Pooled benzodiazepine standard curves containing each of the five benzodiazepines were analyzed separately to obtain intra- and interday precision and accuracy values. Intraand interday accuracies determined for the benzodiazepine analytes were within 1 % and coefficient of variation values were all less than 1 % for concentrations within the measured range (Tables 3 8). The analytes had excellent linearity within the measured ranges with R 2 values greater than.99 (Figures 2 7). Signal suppression was not observed for any of the analytes. Benzodiazepines were quantified between 12, and were determined to have limits of detection (LDs) of less than 2. We recommend using a single blank solvent injection for concentrations higher than 6,2 to minimize the potential for carryover. The addition of a blank injection after a highly concentrated sample increases total sample analysis time to approximately 28 seconds for that sample, which is still several fold faster than traditional LC/MS/MS methods. This method consisting of a standard glucuronidase incubation and dilution for sample preparation followed by quick analysis on RapidFire/MS/MS provides a very efficient mode of quantitatively measuring benzodiazepines in urine compared to traditional LC/MS/MS methods. 3

AUC ratio (Prod/IS) 3 R² =.9999 2 2 1 1 2, 4, 6, 8, 1, 12, 14, Concentration () Table 3. Intraday and interday precision and accuracy for a-hydroxyalprazolam. a-hydoxyalprazolam 11.88 6.84 13.3 8.74 2 9.34.68 93.1 4.8 11.8 2.4 12.6.27 2, 99.31.69 11. 8. 6,2 99.24 7.21 1.21 9.14 12, 13.2 4.4 14.14.98 Figure 2. a-hydroxyalprazolam representative standard curve in urine. AUC ratio (Prod/IS) 3 R² =.9999 2 2 1 1 2, 4, 6, 8, 1, 12, 14, Concentration () Table 4. Intraday and interday precision and accuracy for 7-aminoclonazepam. 7-Aminoclonazepam 18.11 8.2 16. 7.62 2 89.22.37 87.66 3.8 99.6 6.3 13.2 8.11 2, 96.18 6.37 98.67 8.92 6,2 14.4 1.17 13.16 7.18 12, 1.84 3.6 16.39.68 Figure 3. 7-Aminoclonazepam representative standard curve in urine. AUC ratio (Prod/IS) 3 3 R² =.9996 2 2 1 1 2, 4, 6, 8, 1, 12, 14, Concentration () Table. Intraday and interday precision and accuracy for oxazepam. xazepam 13. 7.9 13.8 9.4 2 9.21 6.18 92.3.68 12.47.96 12.39.81 2, 13.7 8.31 1.66 8.29 6,2 1.8.22 11.1 6.6 12, 1.66 6.79 12.42.11 Figure 4. xazepam representative standard curve in urine. 4

AUC ratio (Prod/IS) 3 R² =.9991 2 2 1 1 2, 4, 6, 8, 1, 12, 14, Concentration () Table 6. Intraday and interday precision and accuracy for lorazepam. Lorazepam 11.37.4 1.66 7.39 2 97.94 4.29 9. 4.49 99.71 6.89 13.46 6.86 2, 11.64 3.81 12.46.66 6,2 11.4 4.3 98.29 3.92 12, 98.28 2.73 98.9 3.41 Figure. Lorazepam representative standard curve in urine. AUC ratio (Prod/IS) 12 R² =.9971 1 8 6 4 2 2, 4, 6, 8, 1, 12, 14, Concentration () Table 7. Intraday and interday precision and accuracy for temazepam. Temazepam 14.9 4. 1.37 3.82 2 96.18 4.44 93.71 4.36 96.66 6.3 1.14 6. 2, 11.3 4.6 12.81 6.7 6,2 12.7.79 99.4 4.24 12, 1.49 2.2 11.66 3.7 Figure 6. Temazepam representative standard curve in urine.

Conclusions Analytes from the benzodiazepine class were accurately and precisely quantified using an Agilent High-throughput RapidFire Mass Spectrometry System. Samples containing five benzodiazepine analytes were simultaneously analyzed at 14 seconds per sample, using a high-throughput analytical method of quantitation for these analytes that is capable of analyzing more than 2 samples per hour. This SPE/MS/MS methodology provides comparable results to LC/MS/MS, but at >1x the speed and efficiency of typical LC/MS/MS methods. www.agilent.com/lifesciences/ rapidfi re For Forensic Use nly. This information is subject to change without notice. Agilent Technologies, Inc., 214 Published in the USA, August 7, 214 991-833EN